Introduction
The term "Phakomatoses" (after the word "phakos", meaning birthmark) was formulated by the ophthalmologist Van der Hoeve in the 20 th century when he described the retinal hamartomas [1] . Phakomatoses or neurocutaneous syndromes are a heterogeneous group of congenital disorders with variable degree of penetration, primarily involving structures derived from the embryological neuroectoderm. All those syndromes involve the central nervous system and the peripheral nerves in common; the skin, eye and other systems may also be involved [2] .
The main phakomatoses include neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), tuberous sclerosis complex (TSC), Von Hippel-Lindau (VHL) syndrome and Sturge-Weber syndrome (SWS). But the group of phakomatoses is larger (more than 30 entities) and primarily affect the central nervous system, and less the [4] and the incidence was 1/3000 in USA [5] .
NF2, TSC, SWS and VHL have the same prevalence of 1-9/100 000 in France and an incidence of 1/40 000 for NF2; 1/20 000 for TSC and 1/50 000 for SWS and VHL syndrome in USA according to OMS [6] .
General Pathogenesis
Phakomatoses are a heterogeneous group with an inheritance pattern and variable expression [2] , corresponding in some cases to a new, spontaneous mutation, while in other cases to congenital malformations, hence the importance of performing genetic counseling and genetic testing [3] . The defect is related to a tumor suppression gene (Table I) . They are all autosomal dominant disorders with high penetration (in some cases 100% penetrance) [6] . Although all are inherited dominant neurocutaneous disorders, they are clinically, genetically and radiologically distinct diseases and should be considered as separated entities.
Neurofibromatosis type I (NF1)

I. Pathology
Also named Von Recklinghausen disease, type I neurofibromatosis is known as classical or peripheral phakomatosis, characterized by the involvement of the nerve sheath [2] . Oligodendrocyte myelin glycoprotein and neurofibromin is embedded in gene. This may be responsible for the dysplasia of the white matter lesions in the brain [6] .
II. Clinical issues
The most common clinical presentation is with café-au-lait spots (the earliest sign) and learning disabilities. Two or more criteria must be present for a diagnosis of NF1 (Table II) . As shown in table II clinical and neuroimaging (*) findings are included in the diagnostic criteria for NF1 [2] .
III. Imaging findings: White matter (WM)
lesions may also involve dentate nuclei of cerebellum, globus pallidus, thalamus, brainstem, pons, midbrain, hippocampus [7] . Bone lesions are associated with plexiform neurofibromas. For example scalp lesions which are over the occiput, skull base lesions extending into retropharynx or orbital lesions extending from cavernous sinus through orbit into periorbital soft tissues [6] . The plexiform neurofibromas appear as irregular, cylindrical, fusiform or nodular ill-defined thickening of the major nerve trunks [8] . Visual pathway gliomas can be found at the level of intra-orbital optic nerves (ONG), chiasm/ hypothalamus, optic tracts, lateral geniculate bodies and radiations (Tables III, IV) .
Neurofibromatosis type II (NF2)
I. Pathology
NF2 is a hereditary syndrome characterized by multiple cranial nerve schwannomas, meningiomas and spinal tumors (Table V and VI). It has been considered synonym with "bilateral acoustic schwannomas" [2] .
II. Clinical issues
The most common signs and symptoms are: hearing loss, vertigo, cranial neuropathies, scoliosis, paraplegia or neck pain [2] . Generally there are young patients becoming symptomatic in 3 rd decade with multiple cranial neuropathies, cataracts and extremity weakness.
The diagnostic criteria for NF2 are: Bilateral vestibular schwannomas or 1 st degree relative with NF2 and either a vestibular schwannoma or two of the following: neurofibroma, meningioma,glioma, schwannoma, juvenile posterior subcapsular lenticular opacity (cataract) [9] . Table IV . MRI findings in NF1 (*STIR-short T1 inversion recovery, T1 C+ FS-T1 contrast enhanced T1 with fat suppression, FLAIR -fluid attenuated inversion recovery, MRA-MR angiography, MRS-MR spectroscopy NAA-N-acetylaspartate).
Image 1A axial T2) and 1B (coronal Flair) show focal areas of increased signal intensity in subcortical white matter (FASI) of left parietal lobe in a 10 year old boy with short stature, multiple "café au lait" spots and learning disabilities.
CT Findings
NECT Vestibular schwannoma -cerebellopontine angle (CPA) mass, widened internal auditory canal (IAC), isodense/hyperdense Meningioma -high density dural-based mass Non-neoplastic cerebral calcification(extensive choroid plexus,cortical surface,ventricular lining) CECT Cranial nerve tumor enhancement, meningioma enhancement 
Tuberous sclerosis complex (TSC)
I. Pathology Also known as Bourneville disease, it is an autosomal dominant inherited neurocutaneous syndrome, characterized by the presence of hamartomas that behave as slow-growing painless masses with relatively normal cells in disorganized arrangement. In 60% of cases there is a spontaneous mutation in a tumor suppressor gene [9, 10] .
II. Clinical issues
The most common presentation is with the classic triad: skin lesion (facial angiofibromas), mental retardation and epileptic seizures [11, 12] Diagnostic criteria (Table VII) [13] : -definite diagnosis: two major features or one major and two minor features -probable diagnosis: one major feature plus one minor features -possible diagnosis: one major feature OR two or more minor features
The cortical tubers appear in 95% of patients (50% are cortical and subcortical in frontal lobe) [14] .They are parts of the outer layer of the brain that did not developed correctly and may present a characteristic appearance of an enlarged or misshapen gyrus, with a core of abnormal water signal instead of myelin-matching intensity. It can also calcify over years [13] .
III.Imaging findings
The cortical/subcortical tubers (Image 3) are located mostly in frontal lobe, then parietal, occipital, temporal lobes and less in cerebellum. The best diagnostic tools are CT and MRI (Table VIII and IX) .
At grey scale ultrasound rhabdomyomas are identifiable as early as 20 weeks gestation [9] . Cardiac rhabdomyomas and CNS tumors detected on fetal ultrasound represent a marker of tuberous sclerosis [15] . 
Sturge-Weber syndrome (SWS)
I. Pathology
Also known as angiomatosis encephalo-trigeminal, SWS has an uncertain origin, having raised the possibility of sporadic origin [16] . Most probably there is a somatic mutation or cutaneous mosaicism. At 4-8 weeks of gestation the embryonic cortical veins fail to coalesce and develop and is followed by deep venous occlusion with anoxic cortex [6] . The choroid plexus is commonly involved with an angiomatous change that includes both gross enlargement and increased vascularity [17] .
II. Clinical issues
The intracranial leptomeningeal angiomatosis and bone marrow abnormalities is a key diagnostic feature in SWS [18] . Facial lesion are visible at birth and the seizures develop in the first year of life. The consequences of coroidal angioma is the increased intraocular pressure with buphthalmos [19] . It appear as atrophic cortex with dystrophic calcifications, with consequent widening adjacent subarachnoid spaces -"tram sign". On the basis of the leptomeningeal malformation with consecutive cerebral calcification and progressive cerebral atrophy, epilepsy is often at the forefront of the clinical findings [9] .
CT findings
NECT Subependymal noduls (NsE-50 % calcified by 10 years/along the lateral margins of the lateral ventricles) Tubers -early: low density/ calcifications cortical/ subcortical mass Later: isodense/calcifications Ventriculomegaly common even without AsE CECT Enhancing/enlarging NsE suspicious for AsE 
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III. Imaging findings
The best diagnostic clue is cortical calcium [19] , atrophy and enlarged ipsilateral choroid plexus (Tables X   and XI) . The pialangiomatosis is mostly unilateral (80% of cases) and the occipital lobes are much more affected than the parietal or frontoparietal ones.
CT findings
NECT
Gyral/subcortical WM with calcium (Image 4B), progressive posterior to anterior Late -atrophy,hyperpneumatization of paranasal sinuses,thick diploe CECT Serpentine leptomeningeal enhancement Table X . CT findings in SWS.
MR findings
T1
Increased WM volume subjacent to pial angiomatosis on early stage and atrophy of WM and GM on late stages T2 Early: transient hyperperfusion Late: increased signal in region of gliosis and low cortical signal in calcificated regions [19] Late: Gliosis in involved lobes FLAIR FLAIR T1+ improved visualization of enhancement T2*GRE Tram-track gyral calcifications DwWI
Restricted diffusion in acute ischemia
T1C+
Early: serpentine leptomeningeal enhancement, pial angiomatosis of subarachnoid space (Image 4A) Engorged, enhancing choroid plexus MRS Increased choline and low NAA in affected area 
Von Hippel Lindau syndrome (VHL)
I. Pathology
Hereditary disease of autosomal dominant transmission with incomplete penetration and without skin involvement, unlike most phakomatoses [20] .
The age of onset is variable, uncommon in children. It is characterized by the development of a variety of benign and malignant tumors. The most common causes of death in VHL disease patients are neurologic complications from cerebellar hemangioblastomas (HGBL) and renal cell carcinoma [21] .
II. Clinical issues
The most common lesions are (Tables XII and ) 
III. Imaging findings
CT findings
NECT HGBL in 70% of cases are well-delineated cerebellar cyst with nodule Cystadenoma of endolymphatic sac (ELS) produces destructive changes in petrous bone and intratumoral bone which is stippled, reticular or speculated
CECT
Intense enhancement of tumor nodule 
IV. Discussion and conclusion
Although genetic testing is available, the neurological manifestations of these syndromes cover a wide range, as described in this paper; therefore imaging plays an important key role in identification of abnormalities and follow-up of lesions.
Screening would be useful because some lesions in phakomatoses are treatable. Thus, early detection allows use of more conservative therapy and may improve the patient's quality of life [21] . The best imaging tool is MRI.
For NF1, the evolution ranges from a progressive increase to regression. The best diagnostic clues are: hyperintense lesions on T2W1, plexiform neurofibromas and visual pathway gliomas. Referring to the size, WM lesions can measure 2-20 mm, visual pathway gliomas 3-50 mm and plexiform lesions can be massive [6] .
For NF2 patients with vestibular schwannoma, enhancement is present on T1C+, usually homogeneous, with fat saturation and thin slice profile essential for small CN tumors.
In DWI some meningiomas have restricted diffusion which is mostly characteristic for atypical or malignant meningioma.
In Bourneville disease lesions of cerebellum developed subependymal giant cell astrocytoma in higher percentage than those without lesions of cerebellum [24] . The increased number of tubers increases the neurologic symptoms. WM lesions are along lines of neuronal migration and are cyst-like with the appearance of a cystoid brain degeneration. Thickened cortex and enlarged gyri may also be found. Sometimes these lesions regress spontaneously [6] . Oral rapamycin (sirolimus) therapy has shown promise in inducing regression of AsE and may be an alternative to surgical resection [10, 25] .
For SWS patients the prognosis is dismal if there are early onset seizures, refractory to medical treatment, extensive cortical atrophy and leptomeningeal angioma and if hemiparesis and cognitive deterioration occurs [26] .
